ORGENESIS INC. Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2023-12-29: Form 8-K; Period of report 2023-12-22; Description 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; Details 5.02.
- 2023-11-08: Form 8-K; Period of report 2023-11-08; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events; Details 1.01.
- 2023-10-31: Form 8-K; Period of report 2023-10-30; Description 8.01 Other Events; Details 8.01.
- 2023-10-05: Form 8-K; Period of report 2023-09-29; Description 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2023-12-29 | 8-K | 2023-12-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On December 22, 2023, Mr. Elliot Maltz, the Chief Financial Officer, Treasurer and Secretary of Orgenesis Inc. (the “Company”), resigned from all positions he held with the Company to pursue other opportunities. | form8-k.htm |
| 2023-11-08 | 8-K | 2023-11-08 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 3.02 The information set forth in Item 1.01 above is incorporated herein by reference into this Item 3.02. | form8-k.htm |
| 2023-10-31 | 8-K | 2023-10-30 | 8.01 Other Events | 8.01 On October 30, 2023, Orgenesis Inc. (the “Company”) announced that it has withdrawn its previously announced proposed underwritten public offering of securities due to market conditions. | form8-k.htm |
| 2023-10-05 | 8-K | 2023-09-29 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2023-10-03 | 8-K | 2023-10-03 | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 3.01 On September 27, 2023, Orgenesis Inc. (the “Company”) received written notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days, the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). | form8-k.htm |
| 2023-09-01 | 8-K | 2023-08-31 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2023-07-12 | 8-K | 2023-07-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On July 6, 2023, Neil Reithinger informed Orgenesis Inc. (the “Company”) of his decision to resign as Chief Financial Officer, Treasurer and Secretary of the Company to pursue other opportunities. | form8-k.htm |
| 2023-07-07 | 8-K | 2023-06-30 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. 8.01 As a result of the amendment to the composition of the Morgenesis Board pursuant to the LLC Agreement Amendment described above, Orgenesis expects to deconsolidate Morgenesis (renamed Octomera LLC) from its consolidated financial statements as of June 30, 2023 and to record its equity interest in Morgenesis as an equity method investment. | form8-k.htm |
| 2023-06-13 | 8-K | 2023-06-08 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On June 8, 2023, Orgenesis Inc. (the “Company”) held its 2023 annual meeting of stockholders (the “2023 Annual Meeting”) at 10:00 a.m. | form8-k.htm |
| 2023-05-10 | 8-K | 2023-05-05 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2023-03-31 | 8-K | 2023-03-27 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2023-02-24 | 8-K | 2023-02-23 | 1.01 Entry into a Material Definitive Agreement; 8.01 Other Events | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2023-01-18 | 8-K | 2023-01-12 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |
| 2023-01-13 | 8-K | 2023-01-10 | 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. | form8-k.htm |